219 related articles for article (PubMed ID: 29274925)
1. Role of complement anaphylatoxin receptors in a mouse model of acute burn-induced pain.
Morgan M; Deuis JR; Woodruff TM; Lewis RJ; Vetter I
Mol Immunol; 2018 Feb; 94():68-74. PubMed ID: 29274925
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
4. Complement receptors C5aR1 and C5aR2 act differentially during the early immune response after bone fracture but are similarly involved in bone repair.
Kovtun A; Bergdolt S; Hägele Y; Matthes R; Lambris JD; Huber-Lang M; Ignatius A
Sci Rep; 2017 Oct; 7(1):14061. PubMed ID: 29070810
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
[TBL] [Abstract][Full Text] [Related]
6. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
Li XX; Clark RJ; Woodruff TM
Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.
Bode M; Herrnstadt GR; Dreher L; Ehnert N; Kirkerup P; Lindenmeyer MT; Meyer-Schwesinger CF; Ehmke H; Köhl J; Huber TB; Krebs CF; Steinmetz OM; Wiech T; Wenzel UO
Hypertension; 2024 Jan; 81(1):138-150. PubMed ID: 37909169
[TBL] [Abstract][Full Text] [Related]
8. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
[TBL] [Abstract][Full Text] [Related]
9. IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.
Orrem HL; Nilsson PH; Pischke SE; Kleveland O; Yndestad A; Ekholt K; Damås JK; Espevik T; Bendz B; Halvorsen B; Gregersen I; Wiseth R; Andersen GØ; Ueland T; Gullestad L; Aukrust P; Barratt-Due A; Mollnes TE
Front Immunol; 2018; 9():2035. PubMed ID: 30258440
[No Abstract] [Full Text] [Related]
10. Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosis.
Thorenz A; Derlin K; Schröder C; Dressler L; Vijayan V; Pradhan P; Immenschuh S; Jörns A; Echtermeyer F; Herzog C; Chen R; Rong S; Bräsen JH; van Kooten C; Kirsch T; Klemann C; Meier M; Klos A; Haller H; Hensen B; Gueler F
Kidney Int; 2018 Oct; 94(4):741-755. PubMed ID: 29935951
[TBL] [Abstract][Full Text] [Related]
11. Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration.
Wu MCL; Lee JD; Ruitenberg MJ; Woodruff TM
J Immunol; 2020 Nov; 205(10):2834-2839. PubMed ID: 33028618
[TBL] [Abstract][Full Text] [Related]
12. Anaphylatoxin Receptors C3aR and C5aR1 Are Important Factors That Influence the Impact of Ethanol on the Adipose Secretome.
McCullough RL; McMullen MR; Poulsen KL; Kim A; Medof ME; Nagy LE
Front Immunol; 2018; 9():2133. PubMed ID: 30294325
[No Abstract] [Full Text] [Related]
13. Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury.
Poppelaars F; van Werkhoven MB; Kotimaa J; Veldhuis ZJ; Ausema A; Broeren SGM; Damman J; Hempel JC; Leuvenink HGD; Daha MR; van Son WJ; van Kooten C; van Os RP; Hillebrands JL; Seelen MA
FASEB J; 2017 Jul; 31(7):3193-3204. PubMed ID: 28396344
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients.
Emtenani S; Holtsche MM; Stahlkopf R; Seiler DL; Burn T; Liu H; Parker M; Yilmaz K; Dikmen HO; Lang MH; Sadik CD; Karsten CM; van Beek N; Ludwig RJ; Köhl J; Schmidt E
Front Immunol; 2022; 13():942493. PubMed ID: 36466856
[TBL] [Abstract][Full Text] [Related]
15. The Alternative Receptor for Complement Component 5a, C5aR2, Conveys Neuroprotection in Traumatic Spinal Cord Injury.
Biggins PJC; Brennan FH; Taylor SM; Woodruff TM; Ruitenberg MJ
J Neurotrauma; 2017 Jun; 34(12):2075-2085. PubMed ID: 28173736
[TBL] [Abstract][Full Text] [Related]
16. Role of the NLRP3 inflammasome in a model of acute burn-induced pain.
Deuis JR; Yin K; Cooper MA; Schroder K; Vetter I
Burns; 2017 Mar; 43(2):304-309. PubMed ID: 28040362
[TBL] [Abstract][Full Text] [Related]
17. The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist.
Li XX; Kumar V; Clark RJ; Lee JD; Woodruff TM
Front Pharmacol; 2020; 11():591398. PubMed ID: 33551801
[TBL] [Abstract][Full Text] [Related]
18. The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1.
Shutov LP; Warwick CA; Shi X; Gnanasekaran A; Shepherd AJ; Mohapatra DP; Woodruff TM; Clark JD; Usachev YM
J Neurosci; 2016 May; 36(18):5055-70. PubMed ID: 27147658
[TBL] [Abstract][Full Text] [Related]
19. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
